The new facility, which will be the group's second-largest pharmaceutical manufacturing facility worldwide, will focus on the bulk production and packaging of Glucophage®, Concor® and Euthyrox®, Merck Serono's leading brands for the treatment of diabetes, cardiovascular diseases and thyroid disorders, respectively.
The Ebola outbreak in West Africa eventually could exceed 20,000 cases, more than six times as many as are now known, the World Health Organization said Thursday. A new plan by the U.N. health agency to stop Ebola also assumes that the actual number of cases in many hard-hit areas may be two to four times higher than currently reported. If that's accurate, it suggests there could be up to 12,000 cases already.
The National Institutes of Health announced Thursday that it is launching the safety trial on a vaccine developed by the agency's National Institute of Allergy and Infectious Diseases and GlaxoSmithKline. It will test 20 healthy adult volunteers to see if the virus is safe and triggers an adequate response in their immune systems.
Vantictumab is being studied in combination with standard-of-care chemotherapy in three Phase 1b clinical trials in patients with advanced non-small cell lung cancer (NSCLC), advanced HER2-negative breast cancer and advanced pancreatic cancer.
IBM today announced significant advances in Watson's cognitive computing capabilities that are enabling researchers to accelerate the pace of scientific breakthroughs by discovering previously unknown connections in Big Data.
DuPont will pay a fine of $1.275M to settle a federal complaint over eight chemical releases from a Kanawha County production facility, one of which killed a worker. The Department of Justice and U.S. Environmental Protection Agency said the settlement announced in a statement Wednesday resolves several alleged violations of federal law.
Moberg Pharma AB today announced that its head of U.S. operations, Steve Cagle, has announced his resignation. In order to secure a smooth transition, he will remain in his position until end of January 2015 at the latest.
Currently in Phase 2 clinical development, the vaccine candidate is designed to prevent C. difficile -associated disease, which can include life-threatening diarrhea and pseudomembranous colitis.
This bulk bag unloader system conditions and discharges various semi free-flowing, hygroscopic, contaminable powders at a rate of 8,000 lbs/hr, while feeding the powders to the end-of-line container filling system.
This patented bulk bag material conditioner system utilizes hydraulically actuated, heavy wall tubular steel pivoting conditioning arms.
New research has uncovered a correlation between the antibiotic Clarithromycin and an increase in heart deaths. Despite the connection, researchers say the risk is small, and that doctors shouldn't alter the way they administer the drug.
Introducing pneumatic Scissor Lift and Rotate Systems, designed, engineered and manufactured to specifically fit a customer’s cart for improving ergonomics and productivity in their facility.
Insurers can no longer reject customers with expensive medical conditions thanks to the health care overhaul, but there's still wiggle room for them to discourage the sickest and costliest patients from enrolling.
Introducing a stainless steel version of the WLC60 heavy-duty LED lights, designed for use in extremely harsh conditions.